1007P T-cells transgenic for a highly potent PRAME-specific TCR and a chimeric PD1-41BB co-stimulatory receptor represent a promising approach for the treatment of solid tumors
| Autor: | Bürdek, M., Fetzer, I., Sailer, N., Salvermoser, M., Brechtefeld, D., Mutze, K., Raffegerst, S., Braun, M., Goedkoop, R., Wilde, S., Sommermeyer, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S851-S852 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|